Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company s Refocused Strategy streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
10.05.2022 - Company announcement – No. 16/ 2022 Zealand Pharma Amends Financing Agreement with Oberland Capital as Part of Company’s Refocused Strategy Amendment reduces the outstanding note principal balance from $100 million to $50 million and removes any . Seite 1
/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.
/PRNewswire/ Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today.